Equities

Beijing Hotgen Biotech Co Ltd

688068:SHH

Beijing Hotgen Biotech Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)32.19
  • Today's Change1.93 / 6.38%
  • Shares traded5.95m
  • 1 Year change-33.66%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments6021,4122,082
Total Receivables, Net5212486
Total Inventory135154259
Prepaid expenses395785
Other current assets, total0.21517.07
Total current assets8281,7982,518
Property, plant & equipment, net1,199944589
Goodwill, net------
Intangibles, net555757
Long term investments1,4201,038442
Note receivable - long term------
Other long term assets------
Total assets3,5613,8993,645
LIABILITIES
Accounts payable115263178
Accrued expenses19146135
Notes payable/short-term debt0.8100
Current portion long-term debt/capital leases7.492813
Other current liabilities, total4274409
Total current liabilities185511734
Total long term debt7.761423
Total debt164236
Deferred income tax--9.324.41
Minority interest(1.95)1830
Other liabilities, total9.77119.47
Total liabilities201564801
SHAREHOLDERS EQUITY
Common stock929262
Additional paid-in capital442435458
Retained earnings (accumulated deficit)2,9872,9582,323
Treasury stock - common(166)(150)--
Unrealized gain (loss)------
Other equity, total4.32(0.03)(0.3)
Total equity3,3603,3352,844
Total liabilities & shareholders' equity3,5613,8993,645
Total common shares outstanding899092
Treasury shares - common primary issue2.862.520
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.